Daily Management Review

DMR

Don't Miss

Ukraine’s $44 Billion Climate Claim Against Russia Pivots on Emissions Accountability 11/19/2025

Western Powers Fast-Track Heavy Rare Earth Supply as Chinese Dominance Intensifies 11/19/2025

Market Sentiment Flips as AI Euphoria Collides with Valuation Anxiety and Tightening Policy Signals 11/21/2025

Economics

Business & Finance

Management

World & Politics

Science & Technology

Art & Art Market

Business & Finance

Undersea Fibre-Cables Form the Hidden Backbone of the AI Internet Boom

Investment into global subsea fibre-optic infrastructure is surging — not simply to carry more video or streaming, but because the artificial-intelligence era is shifting the very nature of connectivity. The vast network of undersea cables that has long underpinned the internet is now stepping into...

Why Tesla’s Record $1 Trillion Pay Deal for Musk Marks a Strategic Gamble on Vision Over Valuation

Elon Musk has once again redefined corporate convention. In a decisive show of confidence, Tesla’s shareholders voted overwhelmingly to approve a $1 trillion compensation plan for the billionaire CEO — the largest pay package in corporate history. The vote, held at Tesla’s annual meeting in Austin,...

SpaceX to buy spectrum from EchoStar for $2.6 billion, paying for the deal with own shares

Elon Musk's aerospace company, SpaceX, is buying spectrum licenses from EchoStar Corp. for $2.6 billion. The payment will be made using SpaceX shares, as stated by EchoStar. The deal will happen once all the necessary regulatory approvals are in place. The new agreement comes after a previous...

AMD increases net profit by 1.6x, achieves record revenue in Q3

American chipmaker Advanced Micro Devices Inc. (AMD) reported a significant rise in its net profit for the third quarter, increasing by more than 1.6 times, and revenue grew by 36%, both surpassing what analysts expected. In its press release, the company stated that its net profit for the quarter...

Amazon’s $38 Billion OpenAI Pact Signals a Comeback in the AI Arms Race

Amazon’s landmark $38 billion partnership with OpenAI marks a pivotal turn in the company’s technological trajectory — and perhaps the clearest evidence yet that it no longer trails its Silicon Valley peers in artificial intelligence. Long seen as an e-commerce titan and cloud computing pioneer...

Shein’s High-Stakes Battle for Legitimacy in France’s Fast-Fashion War

Shein, the Chinese-born online fashion giant, is facing its fiercest test yet in France — a country where debates over consumerism, culture, and sustainability have collided head-on with its low-cost retail model. As the company launches its first permanent physical outlet in Paris, it finds itself...

Bloomberg: AI bubble fears are easing thanks to company profits

Profit predictions for companies in the artificial intelligence field are helping to ease worries that the recent rise in global stock markets, driven by interest in this technology, has become a bubble. Bloomberg reports this based on trading data and expert opinions. South Korean chipmaker SK...

Nvidia’s $1 Billion Bet on Nokia Marks Strategic Shift in AI-Telecom Fusion

Nvidia has announced a $1 billion equity investment in Nokia, driving a roughly 22 percent surge in the Finnish telecom-equipment maker’s stock. At the same time, the two companies revealed an alliance to integrate Nvidia’s artificial-intelligence hardware with Nokia’s 5G/6G software, marking a...

Mitsubishi Power expects gas turbine orders to grow by more than 20% in 2025

Mitsubishi Power Ltd. President Takao Tsukui anticipates a major rise in orders for turbines used to produce electricity from natural gas, due to strong demand in the United States and the Middle East, according to Bloomberg. Tsukui forecasts that in 2025, the company's clients will place orders...

Novartis to acquire US rare disease drug developer for $12 billion

Novartis has reached an agreement to purchase the biotechnology firm Avidity Biosciences for a total of $12 billion, which is equivalent to $72 per share—a 46% increase over the company's current stock price. This announcement was made by the Swiss pharmaceutical company. Avidity Biosciences, based...